In an open, nonblind clinical trial, clomipramine reduced adventitious movementsand compulsions in five previously medicated prepubertal boys with autistic disorder andsevere mental retardation. Poorly adapted rating scales, interrater variability, subjectheterogeneity, different treatment histories, and environmental stresses confounded the assessment of treatment effects.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Jul 1994|
ASJC Scopus subject areas
- Clinical Neurology